180 related articles for article (PubMed ID: 25951740)
21. Clinical validity/utility, change in practice patterns, and economic implications of risk stratifiers to predict outcomes for early-stage breast cancer: a systematic review.
Hornberger J; Alvarado MD; Rebecca C; Gutierrez HR; Yu TM; Gradishar WJ
J Natl Cancer Inst; 2012 Jul; 104(14):1068-79. PubMed ID: 22767204
[TBL] [Abstract][Full Text] [Related]
22. Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Adopted on May 17, 1996 by the American Society of Clinical Oncology.
J Clin Oncol; 1996 Oct; 14(10):2843-77. PubMed ID: 8874347
[TBL] [Abstract][Full Text] [Related]
23. Breast cancer: risk factors, screening, and prevention.
Gross RE
Semin Oncol Nurs; 2000 Aug; 16(3):176-84. PubMed ID: 10967790
[TBL] [Abstract][Full Text] [Related]
24. Individualizing care for women with early-stage breast cancer: the role of molecular assays.
Litsas G
Clin J Oncol Nurs; 2013 Jun; 17(3):332-4. PubMed ID: 23715711
[TBL] [Abstract][Full Text] [Related]
25. Liquid Biopsy: A Tool for the Diagnostic and Prognostic Evaluation of Cancers.
Stanciu J; Tariman JD
Clin J Oncol Nurs; 2020 Feb; 24(1):19-21. PubMed ID: 31961840
[TBL] [Abstract][Full Text] [Related]
26. 1997 update of recommendations for the use of tumor markers in breast and colorectal cancer. Adopted on November 7, 1997 by the American Society of Clinical Oncology.
J Clin Oncol; 1998 Feb; 16(2):793-5. PubMed ID: 9469371
[TBL] [Abstract][Full Text] [Related]
27. Ancillary Prognostic and Predictive Testing in Breast Cancer: Focus on Discordant, Unusual, and Borderline Results.
Allison KH
Surg Pathol Clin; 2018 Mar; 11(1):147-176. PubMed ID: 29413654
[TBL] [Abstract][Full Text] [Related]
28. Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline.
Van Poznak C; Somerfield MR; Bast RC; Cristofanilli M; Goetz MP; Gonzalez-Angulo AM; Hicks DG; Hill EG; Liu MC; Lucas W; Mayer IA; Mennel RG; Symmans WF; Hayes DF; Harris LN
J Clin Oncol; 2015 Aug; 33(24):2695-704. PubMed ID: 26195705
[TBL] [Abstract][Full Text] [Related]
29. Breast Cancer Prognostic Tests: Helping Patients Understand Testing Results and Their Implications.
Miller L; Smith EC
Clin J Oncol Nurs; 2019 Oct; 23(5):478-481. PubMed ID: 31538973
[TBL] [Abstract][Full Text] [Related]
30. Information technology and precision medicine.
Carney PH
Semin Oncol Nurs; 2014 May; 30(2):124-9. PubMed ID: 24794086
[TBL] [Abstract][Full Text] [Related]
31. An overview of the management of recurrent breast cancer.
Burnet K
Int J Palliat Nurs; 2000; 6(7):318-9, 322-30. PubMed ID: 11309903
[TBL] [Abstract][Full Text] [Related]
32. Oral Care: Exploring Education, Attitudes, and Behaviors Among Nurses Caring for Patients With Breast Cancer
.
Suminski JA; Inglehart M; Munz SM; Van Poznak CH; Taichman LS
Clin J Oncol Nurs; 2017 Jun; 21(3):371-378. PubMed ID: 28524905
[TBL] [Abstract][Full Text] [Related]
33. [A set of indicators to monitor the adherence to the guidelines for the diagnosis and treatment of breast cancer].
Russo A; Andreano A; Anghinoni E; Autelitano M; Bellini A; Bersani M; Bizzoco S; Cavalieri d'Oro L; Decarli A; Lucchi S; Mannino S; Panciroli E; Rognoni M; Sampietro G; Valsecchi MG; Villa M; Zocchetti C; Zucchi A
Epidemiol Prev; 2014; 38(1):16-28. PubMed ID: 24736958
[TBL] [Abstract][Full Text] [Related]
34. Regulating diagnosis in post-genomic medicine: re-aligning clinical judgment?
Bourret P; Keating P; Cambrosio A
Soc Sci Med; 2011 Sep; 73(6):816-24. PubMed ID: 21664021
[TBL] [Abstract][Full Text] [Related]
35. Precision medicine in oncology standard of care.
Adams L
Semin Oncol Nurs; 2014 May; 30(2):100-8. PubMed ID: 24794083
[TBL] [Abstract][Full Text] [Related]
36. Development of a breast navigation program.
Shockney LD; Haylock PJ; Cantril C
Semin Oncol Nurs; 2013 May; 29(2):97-104. PubMed ID: 23651679
[TBL] [Abstract][Full Text] [Related]
37. Guidelines for Colorectal Cancer Testing: Evidence-Based Practice Recommendations.
Zehnbauer B; Temple-Smolkin R; Monzon FA
J Mol Diagn; 2017 Mar; 19(2):183-186. PubMed ID: 28190460
[TBL] [Abstract][Full Text] [Related]
38. Tumor Heterogeneity in Breast Cancer.
Badve S; Gökmen-Polar Y
Adv Anat Pathol; 2015 Sep; 22(5):294-302. PubMed ID: 26262511
[TBL] [Abstract][Full Text] [Related]
39. The emerging role of the molecular diagnostics laboratory in breast cancer personalized medicine.
De Abreu FB; Wells WA; Tsongalis GJ
Am J Pathol; 2013 Oct; 183(4):1075-1083. PubMed ID: 23920325
[TBL] [Abstract][Full Text] [Related]
40. Establishing the Evidence Bar for Molecular Diagnostics in Personalised Cancer Care.
Schneider D; Bianchini G; Horgan D; Michiels S; Witjes W; Hills R; Plun-Favreau J; Brand A; Lawler M;
Public Health Genomics; 2015; 18(6):349-58. PubMed ID: 26571110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
